비혈관용 스텐트 시장 : 제품 유형, 재료 유형, 최종사용자별 - 세계 예측(2025-2030년)

The Non-vascular Stents Market was valued at USD 1.21 billion in 2023, expected to reach USD 1.30 billion in 2024, and is projected to grow at a CAGR of 7.25%, to USD 1.98 billion by 2030.

Non-vascular stents are medical devices used to support and open passages in the body that are not part of the vascular system, such as the trachea, bronchi, esophagus, biliary duct, and ureter. This scope extends across various fields of medicine, including gastroenterology, pulmonology, and urology. The necessity of non-vascular stents arises from conditions like obstructions due to tumors or anatomical abnormalities, where they provide critical relief by maintaining patency in bodily passageways. Their application spans the insertion into critical passages to alleviate symptoms, reduce complications, and improve quality of life, particularly for patients with cancer or chronic conditions. The end-use scope of these devices predominantly involves hospitals, specialized clinics, and outpatient surgical centers.

Market insights suggest a growth trajectory driven by the increasing prevalence of diseases necessitating non-vascular stent placement and advancements in medical technology that improve stent materials and designs. Opportunities in this market could be leveraged through innovations in biodegradable stents and drug-eluting stents, which can enhance patient outcomes and reduce complications. Geographical expansions into emerging markets also offer potential, given the rising healthcare infrastructure and patient awareness in these regions. However, limitations include the high cost of stent procedures, potential complications such as migration or obstruction of stents, and regulatory challenges that can delay product launches. Furthermore, the competitive landscape is challenging, with key players needing to continually innovate to maintain market share.

Innovation prospects lie in developing personalized stent solutions using advanced imaging and 3D printing technologies, which can promise tailored interventions and improved efficacy. The market reveals a moderate growth nature, influenced by technological advancement, regulatory landscapes, and evolving patient demands. For business growth, focusing on strategic partnerships for technology sharing and navigating regulatory complexities effectively will be crucial. Continuous research and development to improve stent design and functionality while reducing cost and enhancing accessibility will position companies advantageously in this dynamic market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Non-vascular Stents Market

The Non-vascular Stents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of gastrointestinal cancer
  • Growing incidence of urological and pulmonary disorder
  • Rising geriatric population & prevalence of chronic disorders
• Market Restraints
  • Complications in conventional bare stents such as irritate luminal mucosa and produce restenosis
• Market Opportunities
  • Rigourous development in biodegradable polymers and bio-absorbable stent
  • Emerging applications areas such as ophthalmic and neural applications
• Market Challenges
  • Increasing concern associated with complication of angioplasty

Porter's Five Forces: A Strategic Tool for Navigating the Non-vascular Stents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Non-vascular Stents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Non-vascular Stents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Non-vascular Stents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Non-vascular Stents Market

A detailed market share analysis in the Non-vascular Stents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Non-vascular Stents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Non-vascular Stents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Non-vascular Stents Market

A strategic analysis of the Non-vascular Stents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Non-vascular Stents Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, ELLA-CS, Ltd., GE Healthcare, Glaukos Corporation, Hobbs Medical Inc., Medtronic PLC, Micro-Tech (Nanjing) Co., Ltd., Olympus Corporation, PENTAX Europe GmbH, Synchron Med Inc., Taewoong Medical Co., Ltd., and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Non-vascular Stents Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Gastrointestinal Stents, Pulmonary Stents, and Urological Stents. The Gastrointestinal Stents is further studied across Biliary Stents, Colonic Stents, Duodenal Stents, Esophageal Stents, and Pancreatic Stents. The Pulmonary Stents is further studied across Metallic Airway Stents and Silicone Airway Stents.
• Based on Material Type, market is studied across Metallic Stents and Non-Metallic Stents.
• Based on End-User, market is studied across Ambulatory Surgical Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of gastrointestinal cancer
    • 5.1.1.2. Growing incidence of urological and pulmonary disorder
    • 5.1.1.3. Rising geriatric population & prevalence of chronic disorders
  • 5.1.2. Restraints
    • 5.1.2.1. Complications in conventional bare stents such as irritate luminal mucosa and produce restenosis
  • 5.1.3. Opportunities
    • 5.1.3.1. Rigourous development in biodegradable polymers and bio-absorbable stent
    • 5.1.3.2. Emerging applications areas such as ophthalmic and neural applications
  • 5.1.4. Challenges
    • 5.1.4.1. Increasing concern associated with complication of angioplasty
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Non-vascular Stents Market, by Product

• 6.1. Introduction
• 6.2. Gastrointestinal Stents
  • 6.2.1. Biliary Stents
  • 6.2.2. Colonic Stents
  • 6.2.3. Duodenal Stents
  • 6.2.4. Esophageal Stents
  • 6.2.5. Pancreatic Stents
• 6.3. Pulmonary Stents
  • 6.3.1. Metallic Airway Stents
  • 6.3.2. Silicone Airway Stents
• 6.4. Urological Stents

7. Non-vascular Stents Market, by Material Type

• 7.1. Introduction
• 7.2. Metallic Stents
• 7.3. Non-Metallic Stents

8. Non-vascular Stents Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Hospitals

9. Americas Non-vascular Stents Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Non-vascular Stents Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Non-vascular Stents Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Becton, Dickinson and Company
• 2. Boston Scientific Corporation
• 3. CONMED Corporation
• 4. Cook Group Incorporated
• 5. ELLA-CS, Ltd.
• 6. GE Healthcare
• 7. Glaukos Corporation
• 8. Hobbs Medical Inc.
• 9. Medtronic PLC
• 10. Micro-Tech (Nanjing) Co., Ltd.
• 11. Olympus Corporation
• 12. PENTAX Europe GmbH
• 13. Synchron Med Inc.
• 14. Taewoong Medical Co., Ltd.
• 15. W. L. Gore & Associates, Inc.